Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Evommune (EVMN) Shares Outstanding (Weighted Average) (2024 - 2025)

Evommune (EVMN) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 306.86% to $6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2025, up 306.86% year-over-year, with the annual reading at $6.1 million for FY2025, 306.86% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $6.1 million at Evommune, up from $1.5 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $6.1 million in Q4 2025, with the low at $1.5 million in Q4 2024.